Sandoz Group AG (Sandoz Group AG) Other Long Term Assets : $857 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Other Long Term Assets?

Sandoz Group AG's other long-term assets for the quarter that ended in Dec. 2023 was $857 Mil.

Sandoz Group AG's quarterly other long-term assets increased from . 20 ($0 Mil) to Dec. 2022 ($786 Mil) and increased from Dec. 2022 ($786 Mil) to Dec. 2023 ($857 Mil).

Sandoz Group AG's annual other long-term assets increased from . 20 ($0 Mil) to Dec. 2022 ($786 Mil) and increased from Dec. 2022 ($786 Mil) to Dec. 2023 ($857 Mil).

Sandoz Group AG Other Long Term Assets Historical Data

The historical data trend for Sandoz Group AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Other Long Term Assets Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Other Long Term Assets

786.00

857.00

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Other Long Term Assets	786.00	857.00

Sandoz Group AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024